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ABSTRACT 
Background  
There is now global recognition of the reproductive health rights of all individuals, including 
people living with HIV (PLHIV). These include inter alia, decisions on the number, spacing 
and timing of their children.  In light of limited information on the reproductive choices of 
PLHIV at primary health care (PHC) level, the aim of this research study was to develop new 
knowledge on the reproductive concerns and desires of PLHIV and to determine current 
services provided for HIV positive individuals in the Ekurhuleni district of Gauteng Province.  
 
Methods 
A cross-sectional study design was used to explore the reproductive choices and the factors 
influencing these choices among HIV positive patients in the Ekurhuleni district. During 2013, 
a random sample of HIV positive patients attending community health centres was selected. 
After informed consent was obtained, trained fieldworkers administered a structured 
questionnaire that elicited information on socio-demographics, reproductive choices, and 
knowledge on available reproductive services. Survey data were analysed using STATA 
version 13.  
 
Results 
The majority of survey participants (n=430) were female (70%) and unemployed (57 %). The 
mean age of participants was 36 years (SD 8.6): 40.8 years (SD 8.7) for men and 34.5 years 
(SD7.8) for women.  
The expressed desire for children was 46% (95% CI: 41.4 – 50.9). In the multiple logistic 
regression analysis, predictors of desire for children were: age less than 49, marriage or living 
together, and no biological children. The odds of wanting children was 51.5 [95% CI: 14.8–
178.8] times higher for those without children, compared to those with two or more children, 
while for those less than 25 years, the odds of wanting children was 22.0 [95% CI: 1.9-254] 
compared to those older than 50 years.  
 
Conclusion 
v 
 
PHC clinics and health care providers should be capacitated to address the reproductive health 
needs of PLHIV, and these needs should be reflected in provincial and national policies. 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1 Background 
Human immunodeficiency virus (HIV) infection is a global pandemic with great impact on 
population health (1, 2). In 2000, at the United Nations (UN) millennium summit, the United 
Nations Millennium declaration which was adopted gave birth to the eight Millennium 
Development Goals (MDGs). At this summit, the health impact of HIV & AIDS was 
acknowledged and an effective global response was considered essential. Among the eight 
Millennium Development Goals, MDG 6 is to combat HIV and AIDS, malaria and other 
diseases. One of MDG 6b targets was to ensure universal access to treatment for HIV and AIDS 
for all those who need it by the year 2010 while another target is to halt and reverse the HIV 
epidemic by the year 2015 (1, 2). 
 
A decade after the MDGs were launched, the United Nations General assembly in 2011 
endorsed the UN Political Declaration on HIV and AIDS and committed member states to work 
towards the elimination of HIV & AIDS by the year 2015 with set targets, among which are: 
50% reductions of new infections; improvement in treatment coverage; elimination of 
inequalities and gender based violence, stigma and discrimination; and the integration of HIV 
with other health services (3-5). The World Health Organization (WHO), thereafter, developed 
a global health sector strategy on HIV & AIDS, 2011-2015, as part of the broader multi-
sectorial HIV response to guide the health sector’s response to HIV (5, 6). 
 
In 2012, worldwide, there were an estimated 35.3 million people living with HIV (PLHIV), 2.3 
million new infections and 1.6 million deaths from AIDS and related conditions (7, 8). Sub-
Saharan Africa accounts for 69% of the global HIV burden.  Women bear the brunt of the 
epidemic with an estimated HIV prevalence rate of 60% among women in sub-Saharan Africa 
(5, 6). Among the 15-49 year age group, HIV prevalence rate is 17%.  In South Africa, the total 
number of PLHIV increased from an estimated 4 million in 2002 to 5,3 million by 2013, with 
HIV prevalence estimated at 10% of the total population (9-12). 
 
Sexual transmission of HIV infection accounts for more than four-fifths of global HIV 
infections (13). The knowledge on contracting HIV infection has not reduced the risk of PLHIV 
from engaging in unprotected sexual intercourse, often because of their desire for children (14-
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16). The improvement in HIV management especially the introduction of highly active anti-
retroviral therapy (HAART) has transformed the disease from a death sentence to a chronic 
condition, and has resulted in improved quality of life and increased life expectancy of HIV 
positive persons. Consequently, there has been the re-emergence of debates and concerns 
regarding reproductive choices and desires among HIV positive people (17-19). 
 
Sub-Saharan African countries, including South Africa, have limited resources to provide 
adequate health services for the public at large. Health services for HIV positive individuals 
have mainly been in the area of voluntary counselling and testing (VCT) to identify HIV 
positive people and to prevent transmission between sexual partners and from mothers to 
infants through the use of antiretroviral (ARV) drugs, contraception and exclusive 
breastfeeding (20-22). The provision of reproductive assistance for HIV positive persons has 
not received much attention. Hence, the focus of reproductive health has been tailored towards 
the avoidance of pregnancy. Thus, HIV positive persons are commonly counselled on the 
utilisation of contraceptives and the use of condoms (23-25). Worst still, there are reported 
cases of coerced abortion and sterilization as well as pressures to use long-acting contraceptive 
methods (26).  
 
There is now global recognition of the reproductive health rights of all couples and individuals, 
which include decisions on: sexuality, the number, spacing and timing of their children and the 
information and means to do so (27, 28). Consequently, health programme managers, policy-
makers and care providers need to understand and promote the reproductive health of couples 
and individuals and to provide health services that meet their needs. Thus, they are obliged to 
devise mechanisms to ensure that the reproductive rights and needs of PLHIV are protected 
and addressed (29).  
 
In light of limited information on the reproductive choices of PLHIV at primary health care 
(PHC) level, the aim of this research study was to develop new knowledge on the reproductive 
concerns and desires of PLHIV and to determine current services provided for HIV positive 
individuals in the Ekurhuleni district of Gauteng Province. The remainder of this chapter sets 
the scene for the study that was conducted by describing the study setting, outlining the 
problem statement, presenting a review of existing literature, and summarising the rationale for 
the study. The chapter concludes with the study aim and objectives. 
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1.2 Study Setting 
This study was conducted out in the Ekurhuleni health district, one of the five current health 
districts in Gauteng province in South Africa. The other districts in Gauteng province are 
Johannesburg, West Rand, Sedibeng, and Tshwane-Metsweding (30). 
 
Ekurhuleni district is the second largest district in Gauteng province and is divided into three 
operational health sub-districts namely Eastern sub-district (ESDR), Northern sub-district 
(NSDR) and Southern sub-district (SSDR). The estimated population of the district is 2.9 
million people (30, 31). The population with no medical insurance (uninsured population) 
dependent on public health facilities within the Ekurhuleni district of Gauteng province is 
estimated at 1.8 million (32). The major languages spoken in the province are: isiZulu (19.8%), 
English (13.3%), Afrikaans (12.4%), and seSotho (11.6%) (30). 
  
The Ekurhuleni district health system (DHS) consists of a district hospital; Bertha Gxowa 
(previously Germiston) hospital, seven community health centres (CHCs) and 87 clinics. The 
CHCs are well resourced and offered the full package of PHC services including HIV 
diagnosis, treatment and care services (32, 33).  In the ESDR, the CHCs are Nokuthela 
Ngwenya, Kwathema and Phillip Moyo. In the NSDR, there is one CHC which is Esangweni 
CHC and the SSDR has Jabulani Dumane, Phola Park and Ramokunopi CHCs (32).  In 2012, 
Ekurhuleni health district had 98% of the primary health care facilities providing HIV 
management services. A total 39 344 new patients were initiated on treatment bringing the total 
number of patients on HAART to 100 796 as at the end of March 2012 (32, 33). 
 
The management and governance of PHC facilities involve formulating policy for PHC and 
implementing operational management decisions at these clinics. This also involves the 
provision of infrastructure, equipment, pharmaceuticals, the employment of health workers 
and, the monitoring and evaluation of service delivery goals. 
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A total of  572 464  people  have been tested through the HIV Counselling and Testing (HCT) 
Campaign in 2012 of which 19 %  tested positive for HIV. The HIV first test positive rate fell 
from 24% in 2012 to 22% in 2013. The PCR positive rate at 6 weeks also fell from 3% to 2% 
in the same period (32, 33). 
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Figure 1: Map of South Africa, Gauteng province and Ekurhuleni district. 
OR 
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These public health facilities are staffed primarily by nurses and supported by generalist 
medical doctors and family physicians. Health care services are provided free of charge i.e. 
there is no out of pocket payment at these PHC facilities. 
 
1.3 PROBLEM STATEMENT 
In light of the high prevalence of HIV in South Africa, government’s stated commitment to 
address the HIV epidemic in order to meet the millennium development goals (MDGS), policy-
makers and implementers must make all the necessary efforts to improve health services for 
PLHIV. As HIV affects mostly individuals in the 15-49 year age-group, (34) the provision of 
reproductive health services is of particular concern.  This group constitutes the reproductive 
age group and contribute significantly to the economy of the country. 
 
However, little information is available on the reproductive choices of HIV positive patients 
and as well as available reproductive health services in the Ekurhuleni district of Gauteng 
province, where there is an estimated HIV prevalence of 24% (33). The lack of adequate 
information on the reproductive concerns of PLHIV makes the provision of reproductive health 
care and related services difficult. This was one of the first studies to examine reproductive 
choices and desires among HIV patients attending the public PHC facilities in the Ekurhuleni 
district of Gauteng Province, and the availability of such choices.  
 
1.4 Literature Review 
1.4.1 Definition of terms 
HIV positive patient  
An individual who is infected with HIV and who tested HIV positive or reactive to HIV 
antibodies using a recognised, standardised test (35-37). HIV positive (HIV+) patient is used 
interchangeably in this report with the term, people living with HIV (PLHIV). 
 
Sexual and reproductive health  
This is a state of physical, emotional, mental and social well-being related to sexuality, not 
merely the absence of disease, reproductive disease, dysfunction or infirmity. Sexual health 
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requires a positive and respectful approach to sexuality and sexual relationships, as well as the 
possibility of having pleasurable and safe sexual experiences, free of coercion, discrimination 
and violence (38, 39).  
 
Furthermore, sexual and reproductive health also implies that people have the capability to 
reproduce and the freedom to decide; when and how often to do so. Integrally, is the right of 
men and women to be informed and have access to safe, effective, affordable and acceptable 
methods of family planning of their choice, as well as other methods of choice of fertility 
regulation and the right of access to appropriate health care services that will enable women to 
go safely through pregnancy and childbirth and to provide couples with the best chance of 
having a healthy infant (38, 39).  
 
Sexual and reproductive health services 
The main components of sexual and reproductive health services are: improvement of 
antenatal, perinatal, postpartum, and new-born care; provision of high-quality services for 
family planning, including infertility services; elimination of unsafe abortions; prevention and 
treatment of sexually transmitted infections, including HIV, reproductive tract infections, 
cervical cancer, and other gynaecological morbidities; and promotion of healthy sexuality (40). 
 
Reproductive Rights 
WHO defines reproductive rights as basic rights for all couples and individuals to decide freely 
and responsibly the number, spacing and timing of their children and to have the information 
and means to do so, and the right to the highest attainable standard of sexual and reproductive 
health. It also includes the right of all to make decisions concerning reproduction free of 
discrimination, coercion and violence (41, 42). 
 
 
 
 
Assisted reproductive technology (ART) 
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This is defined as all treatments or procedures that include the in-vitro handling of both human 
oocytes and sperm, or embryos, for the purpose of establishing a pregnancy. This includes, but 
not limited to, in-vitro fertilization and embryo transfer, gamete intra-fallopian transfer, zygote 
intra-fallopian transfer, tubal embryo transfer, gamete and embryo cryopreservation, oocyte 
and embryo donation, and gestational surrogacy. This definition is not inclusive of assisted 
insemination/artificial insemination (43-45). 
 
Artificial Insemination 
Artificial insemination (AI) is a procedure that involves the direct insertion or introduction of 
semen into a woman's vagina or womb other than by coitus. The most commonly used method 
of artificial insemination is intrauterine insemination (IUI) and other types such as intra-uterine 
tubo-peritoneal insemination (IUTPI), intra-cervical insemination (ICI), intra-tubal 
insemination (ITI) (46-49). 
 
1.4.2 Studies in high income countries 
In the early stages of the HIV epidemic, the advice given to HIV positive patients was to 
postpone pregnancy due to the anticipated poor health condition of women and vertical 
transmission of the infection to their babies. This was the policy position of the Centres for 
Disease Control and Prevention (CDC) in 1985 (50, 51). The American College of Obstetrics 
and Gynaecology (ACOG) added its voice to the debate in 1987, and urged physicians to 
discourage women infected with HIV from falling pregnant, and to inform pregnant HIV 
infected women of termination options (52, 53). 
 
In 1994, the attitude towards reproductive concerns of persons living with HIV started 
softening. The Ethics Committee of the American Society for Reproductive Medicine (ASRM) 
among its guidelines for HIV positive patients requesting reproductive assistance, advised 
physicians to counsel couples about the consequences of using potentially infected sperm and 
to discuss the options of donor sperm, adoption, or not having children. At this period, the life 
span was considered to be short for the potential child’s parent and also HIV was regarded as 
a contra-indication for a healthy pregnancy (54-57). Subsequently, the provision of 
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reproductive services in several high income countries was recognised as a legitimate right.  
These services are currently being offered in Europe and in France where assisted reproductive 
techniques have been offered free of charge since 2001 (58).  
 
In 2001, the CDC revised its previous position and recommended that HIV-infected pregnant 
women should receive information about all reproductive options and that reproductive 
services should be guided by a patient decision (59). 
 
There is a significant body of literature on reproductive choices of and issues faced by PLHIV. 
In a 1996 study by Chen et al, among HIV positive patients receiving treatment in HIV clinics 
in the United States of America (USA), 28% of men and 29% of women expressed their desire 
to have children in the future irrespective of HIV infection. Factors influencing this desire 
included younger age and personal health status. Race and ethnicity were found to play a role 
as those of African descent were more likely to desire children than others (60). In Canada a 
study by Ogilvie in 2007, reported that 25.8% of women living with HIV (WLHIV) expressed 
an intention to have children. In the multivariate model analysis, non-aboriginal ethnicity, 
younger age and having a regular partner were associated with an increased likelihood of the 
reported intention to have children (61). 
A French study by Heard et al in 2007 reported that among heterosexual PLHIV receiving 
treatment in various hospitals, 32% of women and 20% of men expressed a desire for children. 
The motivating factors were similar to those found by Chen et al (60). In London Sherr et al 
found that 43.8 % of HIV positive men attending HIV clinics wanted children, (62) while the 
2003 Panozzo et al study in Switzerland, found that among PLHIV, 38% of men and 45% of 
women expressed a desire for parenthood (63). 
 
1.4.3 Studies in low and middle-income countries 
In general, several studies have reported the immense pressure on women in sub-Saharan 
Africa to have children regardless of their HIV status (64). The situation for men was reportedly 
grave as well, with not having children often resulting in stigmatisation and loss of social status 
among peers (41). Thus, there is strong desire among PLHIV to bear children. This means that 
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couples who lack services to guide them on their reproductive choice, are left with no 
alternative than to be involved in unprotected risky sexual behaviour (42, 62, 65-67). 
 
Several research studies on the reproductive concerns of HIV positive patients have been 
published with interesting findings. In a cross sectional study in Uganda to investigate desire 
for children and pregnancy risk behaviour among HIV infected men and women, it was found 
that 33% practised pregnancy risk behaviour, and 18% desired more children. Men were almost 
four times more likely to want more children than women (27% vs. 7%) (68). Beyeza-Kashesya 
et al examined determinants of the desire for children among 114 mutually disclosed sero-
discordant couples receiving care at four centres in Kampala, Uganda.  They found out that 
59% of the participants desired to have children and they believe that their partner wanted 
children was a major determinant of the desire to have children irrespective of the person’s 
HIV sero-status.  Among couples where the woman was HIV-positive, younger age and 
relatives' expectations for children and among couples where the man was HIV positive, 
knowledge of ART effectiveness was associated with increased fertility desire (69). 
Availability of information on contraception was associated with decreased fertility desire (69). 
Although this study was done in a different context than South Africa, it highlights the fact that 
HIV disclosure and HIV treatment are not the only motivating factors for the desire to have 
children. 
 
In another study on ‘Sexual relationship and childbearing decisions of HIV-discordant couples: 
an exploratory study in South Africa and Tanzania’, more than half of the South Africans and 
almost three-quarters of the Tanzanians reported that intimacy had been affected by their 
discordant status. Those without children were more likely to desire children (17/23) than those 
who already had children (16/44). In this study among HIV discordant couples, this desire was 
influenced by fear of HIV transmission to the negative partner and medical professional advice 
(70). The study points to the need for targeted information for HIV discordant couples, as well 
as couple counselling and support services. 
 
The desire for children among women living with HIV (WLHIV) was also reported in research 
conducted in Brazil, Uganda, and Zimbabwe (71-73) and  was found to be independent of  
HAART (74-76). In Uganda and Zimbabwe, younger age and stable relationship status were 
factors associated with reproductive desire, (77, 78) while in Brazil the desire to have a child 
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with the  current partner was reported as a reason (71). In India, desire for a male child was the 
strongest determinant among PLHIV, (79) while in Fiji, Papua New Guinea and Botswana, the 
cultural dictate of motherhood was the  main determinant for desiring children (80, 81). 
 
Coerced sterilization, the performance of female sterilization without informed consent by the 
concerned individuals, have been reported among PLHIV in Namibia (82) and Brazil (71). In 
these instances health care providers (HCPs) decided on sterilization options for women (71, 
83). In 2011, coerced sterilisation was also reported by the International Community of Women 
Living with HIV/AIDS in Namibia (82, 84), Thailand (85, 86), Chile (83, 87), Mexico (88, 89) 
and Jamaica (90). The International Federation of Gynaecology and Obstetrics released an 
update on female contraceptive sterilization guidelines that recognized coerced sterilization as 
violence against women (91). 
 
Several articles have been published examining the legal and human rights issues of people 
living with HIV and their reproductive concerns. In an article “At risk: Rights violations of 
HIV-positive women in Kenyan health facilities”, those who expressed the desire to have 
children were faced with biases and negative attitudes by health care providers and they 
reported being stigmatised in their communities (92). In this hostile environment and the health 
care workers not providing the opportunity for HIV positive persons to raise their reproductive 
concerns, PLHIV often conceal their desires, leading to  grave consequences of engaging in 
risky sexual practices and sexual transmission of HIV infections (92). The article “Desire to 
have children: gender and reproductive rights of men and women living with HIV: a challenge 
to health care in Brazil”, re-iterates the sexual and reproduction rights of HIV positive persons 
(93).          
 
Negative attitudes about pregnancy among HIV positive women were also reported. HIV 
positive women are sometimes advised to abstain from sex, pressured to abort current 
pregnancies or refused health care. This situation has been reported in India, Kenya and other 
developing countries (74, 94-99).  Many HIV-positive women want to discuss their sexual 
and reproductive plans with their health care providers, but do not feel comfortable. This was 
the findings of research studies in Mexico, Brazil, South Africa and Chile (94, 100-102). 
Stigma, hostility and discrimination were also reported. In some instances PLHIV are 
reported to have refused to attend antenatal care or avoided hospitals at the time of delivery 
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because of the perceived high levels of stigma, discrimination and even hostility. This has 
been reported in India, Swaziland, Mozambique and other countries (94, 103, 104).  
 
There are numerous challenges in the provision of ART services for women living with HIV 
(WLHIV) in these developing countries. In Kenya, financial constraints were the major 
obstacle (105) while in Vietnam the government policy placed prohibition on the provision of 
this service (106). The situation in eight Latin America countries is that ART is excluded from 
the national strategic plan (107). Due to lack of ART, women living with HIV are exposed to 
risky sexual behaviour and thus faced with the increased risk of horizontal and vertical 
transmission of HIV.  
 
The reported findings that  HIV affects fertility of WLHIV has made the provision of the ART 
service difficult as the chances of positive outcomes with ART is reduced compared to those 
without the infection (108-113).  
 
1.4.4 Studies in South Africa 
In the study report by Cooper et al, to investigate the fertility intentions and reproductive health 
care needs of PLHIV attending health care facilities in Cape Town, 57% of men and 45% of 
women expressed their intention to have children.  Overall, intentions to have children were 
associated with being male, having fewer children, living in an informal settlement and use of 
antiretroviral therapy. There were important gender differences in the determinants of future 
childbearing intentions, with being on highly active antiretroviral therapy (HAART) strongly 
associated with women’s fertility intentions. The study participants gave some insights into the 
reproductive desires of HIV positive patients attending these clinics (114).  
 
In Soweto, Kaida et al reported in 2007, the desire for children among HIV positive women on 
HAART was 31% and was associated with younger age and being in a stable relationship (74).  
In the study report by Strode et al, participants gave accounts of discrimination and coerced 
sterilization of HIV positive  women in two provinces between 1996 and 2010 (115).   
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1.4.5 Reproductive options for PLHIV 
Several articles have been published to examine reproduction options that can assist PLHIV 
achieve their reproductive desires, dignity and right and as well as reduce HIV transmission.  
These include services for the prevention of mother-to-child transmission (PMTCT) of HIV 
programme during pregnancy and delivery, elective Caesarean section and avoidance of breast 
feeding. The reduction in transmission, if all these measures are implemented, is less than 2% 
from about 30% without any intervention (116, 117).   
 
Natural reproduction through unprotected sexual intercourse is supported by current research 
findings that the risk of HIV transmission is reduced if the viral replication is completely 
suppressed to an undetectable level. It has been reported in research findings that HAART 
taken for 4-6 months could lead to suppression of the viral replication to an undetectable level. 
Thus, the risk of HIV transmission is reduced but not completely eliminated (118).  The study, 
known as HPTN 052, found that early initiation of anti-retroviral therapy (HAART) by HIV 
infected individuals substantially protect their HIV uninfected sexual partners from acquiring 
HIV infection at 96% reduction in risk of HIV transmission (119). This finding holds promise 
for countries that are currently struggling to cope with declining health budgets, yet increasing 
health care needs. As a consequence of this finding, the recommendations are natural 
reproduction through unprotected sexual intercourse, and the restriction of these sexual 
encounters to ovulation periods and a maximum of 12 attempts, in order  to minimise HIV 
transmission and maximise conception (16, 119). However, caution is advised in these 
proposals since the risk of HIV transmission can only be minimised but never eliminated (120-
122). 
 
Assisted reproductive methods have been advised in light of the finding that in discordant 
partners where the man is HIV positive and the woman is HIV negative, the risk of HIV 
transmission through unprotected sexual intercourse is still present even if HIV is suppressed. 
This is because men with undetectable plasma viral load (VL), such as those on HAART can 
still transmit HIV in semen. The explanation is that viral load in semen correlates poorly with 
that in serum. HIV test of semen for the detection of HIV antigen in the ejaculates of semen is 
unreliable (123-126). The recommended approach to achieve pregnancy is through methods 
such as insemination using donor sperm after the donor sperm is screened and free of HIV and 
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other infections or by means of sperm washing of the infected male sperm before intrauterine 
insemination (IUI), in-vitro fertilisation (IVF) or intra-cytoplasmic sperm injection (ICSI) 
(127, 128). 
 
In the case where the woman is HIV-positive and the man is negative, the finding is that despite 
full viral load suppression in the woman through HAART, detectable HIV has been identified 
in follicular fluid and endometrial samples (21, 129). In this situation, since it is still not safe 
for unprotected sexual intercourse, to achieve pregnancy, the advice is by way of self or assisted 
insemination of semen. This service is available in low income countries and many HIV 
positive patients have benefited from it. 
 
Generally, the means through which risk of HIV transmission can be reduced for safer 
conception in sero-concordant and sero-discordant couples now include giving HAART for 
viral load suppression in the positive partner(s) and practising timed, limited, peri-ovulatory 
unprotected sexual intercourse. Another option is the intra-uterine insemination and intra-
vaginal insemination of sperm free of HIV, through sperm washing of semen from a HIV 
positive individual (67). Male circumcision have been found to reduce HIV transmission by 
60%, post-exposure prophylaxis (PEP) in the negative partner and partner pre-exposure 
prophylaxis (PrEp)) in the negative partner show promise of reducing transmission of HIV 
through sexual intercourse but at experimental stages (52, 67).  
 
In summary, the review of the literature shows that desire for children among PLHIV is a reality 
in all countries, and several complex factors determine the reproductive choices. The 
knowledge of methods to reduce HIV transmission via reproduction processes is available and 
the right for reproductive options for HIV patients have been well articulated. Notwithstanding 
the various options available, many of which are accessible in high income countries, these 
services are neither available nor affordable in resource-constraint settings such as South 
Africa.  
 
As indicated earlier the availability of services and reproductive desires and choices of HIV 
patients at PHC facilities in Ekurhuleni district were unknown. This study was conducted to 
address this knowledge gap, and to contribute to the discussions on improvements in service 
delivery to PLHIV within the district specifically, but broadly within the province of Gauteng. 
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1.5 JUSTIFICATION FOR THE STUDY  
There were several reasons for conducting a study on the reproductive choices of HIV positive 
individuals attending the HIV clinics in Ekurhuleni for care and treatment. Firstly, the study 
generated locally, context specific information on the: choices of HIV patients with regards to 
reproduction and the factors influencing these choices, and PLHIV’s knowledge of fertility 
options and services available to them at the PHC facilities in Ekurhuleni area.  
 
Secondly, the study was important from a human rights perspective as the information could 
inform the establishment and/or improvement of reproductive health services as part of PHC 
services for HIV patients in the Ekurhuleni district. 
 
 In light of the renewed emphasis on quality of care, the study findings also provided a baseline 
for programme or service monitoring in the district.   
 
Lastly, the study findings are relevant to similar districts in Gauteng province and in the 
country.  
 
1.5.1 Aim 
The aim of this research study was to investigate the reproductive choices of HIV positive 
patients in Ekurhuleni district, Gauteng Province. 
 
1.5.2 Objectives 
The specific objectives of the study were to: 
1) Determine reproductive desires of HIV positive individuals attending HIV clinics 
2) Explore factors influencing reproductive choices of HIV positive patients. 
3) Determine the knowledge of HIV positive patients on the reproductive options available to 
them. 
4) Explore the reproductive services received at the Ekurhuleni clinics by HIV positive 
patients. 
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The next chapter, materials and methods describes in detail the processes undertaking to 
conduct the research. 
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CHAPTER 2:  MATERIALS AND METHODS  
2.1 Introduction 
This chapter describes the overall study approach and methods (sampling, data collection and 
analysis) which were in line with the study aim and objectives.   
 
2.2 Study population  
The study population consisted of all the HIV positive patients attending the primary health 
care facilities within the Ekurhuleni district.  
 
2.3 Study Design 
This was a cross-sectional study conducted during 2013 to describe the reproductive choices 
of HIV positive patients in Ekurhuleni district of Gauteng province.   
 
2.4 Ethical considerations 
Standard ethical procedures were followed: ethical clearance for the study was obtained from 
the University of the Witwatersrand’s Human Research Ethics Committee (Appendix 1a), the 
study approval was also obtained from the Ekurhuleni health district research ethics 
committees (Appendix 1b), a detailed patient information sheets were given to patients 
(Appendix 2), informed consent form was obtained from every patients (Appendix 3) and there 
was voluntary participation in the study.  
 
Patients attending the HIV clinics were informed about the research project. Those who were 
selected were informed that participation was entirely voluntary, with no direct benefits or 
penalties irrespective of their decision about study participation. All selected participants were 
given the information form and consent form (see appendices 2 &3).  
 
The information form and the research process were explained to each participant. Those who 
decided to participate in the study then signed the informed consent to participate. Following 
informed comment, the questionnaire thereafter was administered by their fieldworker.  
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Those who needed support and counselling as a result of emotional trauma experienced from 
the contents of the questionnaire were referred to the lay counsellor based at each clinic. 
Participants requesting more information on the research that could not be handled by the field 
workers were referred to the researcher.   
 
The nurse dedicated to the research and the fieldworkers ensured that participants did not lose 
their place in the queue at the PHC facility, because of participation in the study.  
 
Also as part of the information on the information leaflet, it was clearly stated that there was 
no direct benefit to participants and this research may not result in additional or improved 
services by the government. This was necessary to ensure that possible unmet expectations 
from the research did not lead to resentment towards health workers at the PHC facilities 
involved in the study. 
 
2.5 Eligibility criteria 
The eligible age for inclusion in the study was 18 years to avoid ethical and legal issues with 
obtaining consent from minors to participate in the study. Women between their reproductive 
years of 18-49 years were eligible while men aged 18-60 years were included in the study. All 
those who are too sick to be interviewed or who declined participation were also excluded from 
the study.  
 
2.6 Sampling 
2.6.1 The sampling frame 
The sampling frame consisted of all HIV positive patients attending the seven CHCs in 
Ekurhuleni heath district. The CHCs were selected as they are well resourced, provide 
comprehensive PHC services, have dedicated HIV clinics and attend to a large number of the 
HIV positive patients. The CHCs in the whole district are grouped into the sub-districts of east 
(ESDR), north (NSDR) and south (SSDR) as indicated in Chapter 1.   
Each HIV clinic in the sampled facilities has an average head count per week of 500 HIV 
positive or 2 000 patients per month. The female to male ratio is 70:30.   
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2.6.2  Sample size calculation 
The study sample size was determined using the sample size calculation formula:  
N = Z2 x p (1-p) 
            D2  
(Where N is sample size, Z is 95% (1.96) confidence interval (CI); p is proportion of the 
outcome variable (desire for a child/ children) from previous study (60%) and D margin of 
error (5%).  
Thus,   N=1.962 x0.6 (1-0.6) = 369.  
                        0.052 
Therefore, the total number of HIV positive patients required for the study was 369 patients 
and with the assumption of about 20% refusal rate, the sample was then adjusted to 442.  
 
2.6.3  Sampling approach 
One CHC from each of the two sub-districts - east and south - was sampled randomly using a 
simple ballot method while the only CHC from the north was selected. This sampling approach 
was used to account for the geographical distribution of the PHC facilities in the district. The 
study participants were selected from these sampled CHCs.  The female: male ratio of 70:30 
was maintained in the sampled participants. 
 
The participants were selected using systematic sampling with a random start (between 1 and 
10). All the patients attending the HIV clinics on each day were given serial numbers, with 
separate codes given to men and women.  The numbering started from M001 for men while 
women had W001 until the last patient. The total number of participants expected for each 
particular day was firstly  determined and the interval then derived by dividing the total number 
of patients attending the clinic by the expected number of study participants to be interviewed. 
The selection of participants was then started from the random number selected and the interval 
followed to get the exact number of expected participants for both men and women 
respectively.  
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Every eligible patient within the determined intervals who was willing to participate in the 
study was selected and included in the study. This approach was adopted for each working day 
in the months of May to July 2013 until the sample size was reached.    
 
  
 
 
 
 
 
 
Figure 2: Overview of sampling approach 
A dedicated nurse at each health centre assisted to identify the files of attending HIV positive 
patients and to allocate the serial numbers. The field workers then sampled the participants 
from these patients using the sampling sequence.  
 
Arrangements were made for all patients participating in the study to maintain their position or 
number on the queue for the clinic services. 
 
2.7 Measurement Tools and Data Collection 
2.7.1  Questionnaire design, content and validity 
A semi-structured questionnaire, developed in line with the study objectives, was used to 
collect data (see appendix 4). The questionnaires were administered by trained field workers. 
The questionnaire covered the following key domains: background characteristics; HIV 
disclosure and treatment; reproductive choices; and the available clinic services. In the domain 
of reproductive choices, the questionnaire included the following: sexual relationship(s); desire 
to have a child / children in future; reasons for the expressed choice; condom use; contraceptive 
3 CHCs sampled 
Calculated 
required sample 
size =369 
Eligibility criteria applied: 
Exclude  
 too sick,  
 below 18 years  
 and above 60 years for men 
 
Participants sampled, 
maintaining male: 
female ratio 
separately. 
Presumed refusal 
rate=20%, sample size 
adjustment = 442 
 
Participants sampled = 
430 
Sampling process 
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use; and choice of reproductive method (e.g. natural, artificial insemination, assisted 
reproductive technology, etc.). The questionnaire also explored the participants’ reasons for 
not wanting children in the domain of reproductive choices. 
 
The validity of the questionnaire was ensured by accuracy of translation from English to the 
other languages, the pilot study that was done, the sequence of the content and the consistent 
usage for all participants. 
 
2.7.2  Questionnaire translation 
The content of the questionnaire were developed from findings of the reviewed literature. 
These variables contained in the questionnaire have been validated and used in several research 
studies relating to reproductive health of PLHIV as evident in published research. The 
questionnaire was developed in English, but was translated into seSotho and isiZulu, because 
these are the predominant languages spoken in the district. The translations were done by 
capable persons who are health care providers, fluent in speaking, reading and writing in these 
languages. The back translations were done by other individuals at the health facilities who 
were fluent in speaking, reading and writing these languages to ensure accuracy and validity 
of the translations.  
 
This processes revealed differences in some of the meanings in the translated documents from 
what were intended in the English version. These differences were resolved by another group 
of individuals who were also competent in these languages.  
 
The final document, a product of these rigorous activities ensured the questionnaire was valid 
and that enabled appropriate data collection. 
 
2.7.3 Field workers  
The fieldworkers who collected the data were recruited from the district. Criteria used for their 
recruitment included among others: experience in research, fluency in in English, isiZulu and 
seSotho, and ability and willingness to travel to research site. A training workshop was 
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organised for the field workers. These fieldworkers were taught appropriate conduct and 
behaviour during research and with study participants and the training also focused on their 
important role in the research. The workshop covered limited theoretical aspects to understand 
the research process and the administration of the questionnaires. Thereafter, a practical session 
on the administration of the questionnaires was conducted.  
 
Assessments were done and those who demonstrated good understanding of the research 
process and use of the information document, consent and questionnaire were selected. Nine 
candidates, four females and five males, participated in the recruitment exercise, seven made 
the final list. 
 
The practical assessment of the fieldworkers continued at the pilot site and one of the 
candidates was dropped due to poor performance. Eventually, three females and three males 
administered the study questionnaires. 
 
The field workers then signed a contract which explained the relationship between them and 
the researcher. These included among others: the amount of stipends to be paid, responsibility 
in the completeness of data collected, signing of attendance and most importantly, that this 
research field work was neither an employment nor a promise of eventual employment. This 
last aspect is important in South Africa because of the high unemployment rates. 
 
2.7.4 Pilot study 
A pilot study was carried out at a CHC not included in the study, but located within the district. 
The pilot study was aimed at testing the duration of the questionnaire as well as to ensure the 
validity of the elements contained in it. The time to administer a questionnaire determined 
through this process was 30 minutes on average and the elements in the questionnaire were 
found valid for the research study.  
 
This pilot study also helped to determine acceptability, suitability, understanding and 
willingness of PLHIV to participate in the study. 
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It also helped to assess the field workers ability to question participants, complete the 
questionnaires, respond to questions and handle emotional issues experienced by respondents. 
  
2.7.5 Data collection  
Six field workers were used to collect the data. Two field workers, one female and the other 
male, were used to administered questionnaires to the participants in each clinic. The female 
fieldworker administered the questionnaires to female patients while the male fieldworker 
focused on the male patients. 
 
The data collection started on 15 April 2013 and ended on 30 May 2013, and took place 
between 7.30am and 4.30 pm each clinic day. About ten to twenty patients were interviewed 
on a daily basis. The average time for each participant was between 20-30 minutes. 
 
Some of challenges encountered during the data collection period included among others: 
delays in starting in some clinics due logistical issues, some clinics did not operate on some 
days of the week, all clinics were closed during weekends and some of the field workers were 
absent for social reasons on some days of the week.  
 
There was general willingness among patients to participate when the purpose of the study was 
explained to each of them in the private room used by the research fieldworkers. 
  
2.7.6  Quality and reliability of the data 
The interview was conducted in a private room in each of the facilities.  This enabled open 
discussions and confidential completion of the questionnaires.   
 
The researcher ensured each data collection centre (namely the selected CHC) had dedicated 
numbered questionnaires. All completed questionnaires were checked daily or within two days 
for: completeness; appropriateness of responses to all of items; and legibility of the writing. 
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Thereafter the completed questionnaires were put in an envelope, sealed and the date of data 
collection written on them. 
   
2.8 Data Management and Analysis  
The questionnaires were coded for each facility and participant using the following 
abbreviation; the Eastern clinic: E (E001, E002 etc.), Southern clinic: S (S001, S002 etc.) and 
Northern clinic: N (N001, N002, etc.). To maintain confidentiality, the names of participants 
were not written on the questionnaire and at the end of the research they were filed in a folder 
securely locked in the family medicine office in the district which can only be accessed by the 
researcher. 
 
The data were captured in excel file (data entry). The descriptive and inferential statistical 
analyses were done using STATA® 13.  
 
2.8.1 Data analysis 
The descriptive analysis included calculation of the numbers and frequencies of the following: 
socio-demographic characteristics of the study participants such as age, educational 
qualification, marital status and home language; reproductive choices expressed by participants 
(e.g. desire to have a child / children); knowledge of the reproductive options available; and 
reproductive services received at the CHCs.  
  
In the inferential statistical analysis, the variables examined included the following: 
associations between socio-demographic characteristics such as: age, marital status, number of 
children, and level of education, employment and home language, and reproductive desires, 
reasons for reproductive desires, availability of reproductive services, and knowledge of 
reproductive options and disclosure of HIV status.  
 
The Chi square test was used to determine the level association of the factors influencing 
decision to have a child / children. The odd ratio and p-value were determined for each of the 
factors. Univariate logistic regression models were fitted to find factors which were 
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independently associated with desire to have children. Only factors associated with desire for 
children that were found to be statistically significant were considered in the model building 
exercise using a multiple logistic regression model. All statistical tests were carried out at 5% 
significance level. 
 
2.9 Addressing potential sources of bias in the study 
In any research project, the possibility of bias existed and several measures were taken in this 
research study to minimise bias. 
 The calculated sample was increased by 20% to deal with potential refusals or non-
respondent bias. 
 Random sampling was used in the research to identify the clinics and to select the patients. 
Thereby, all patients had an equal chance of being selected, thereby avoiding sampling bias. 
 The validity of the questionnaire was ensured through clear questions, quality control, 
trained fieldworkers, pilot testing and ensuring the same questions were asked consistently. 
 The data collection was done by trained research fieldworkers.  
 The data was collected within a time frame of two weeks. This was done to avoid 
duplication of selection of patients returning for their monthly medications. 
 The researcher ensured quality, by checking data collection on a daily basis.   
 Patient records were readily available should a participants not remember any requested 
information. Thereby, recall bias was minimised. 
 Double data entry was done and was verified by the researcher before analysis was done. 
This was ensure accuracy of the captured data 
The following chapter focuses on the research findings. 
 
  
26 
 
CHAPTER 3: RESULTS 
__________________________________________________________________________ 
3.1 Introduction 
The study recruited 439 participants, there were no participant refusals, representing a 100% 
response rate.  
Nine participants were older than the eligible age and were excluded from the analysis. 
Therefore, the final number of participants was 430 participants: 128 men and 302 women. The 
main study findings are summarised in Box 1 below. 
Box 1: Summary of main study findings 
SUMMARY OF MAIN RESULT FINDINGS 
1. Socio-demographic characteristics of study participants: the majority of the sampled 
participants (420) were females (70%). The mean age of participants was 36 years (SD 
8.6): 40.8 years (SD 8.7) for men and 34.5 years (SD7.8) for women. The majority of 
participants (57%) were unemployed 
2. HIV Diagnosis, Disclosure and Treatment: 93% of participants were on HAART and 
disclosure of HIV status was done by the majority (95%) but mainly to own family 
members. 
3. Current health status and discrimination: 77% of participants described their health 
status as good or excellent. 
4. Contraception: The preferred family planning method for women was the injectable 
contraceptive (60%). 
5. Reproductive choice: (46% of participants expressed the desire for children, and the 
majority (55%) wished to have doctors’ advice on reproductive options. 
6. The predictors of the desire for children were: age younger than 49 {below 25 
years (AOR=22.0; 95% CI: 1.9-254)},  being married (AOR=3.0; 95% CI: 1.0 – 8.6) 
or living together (AOR=3.7; 95% CI: 1.3 – 10.6) and having no child (AOR=51.5; 
95% CI: 14.8–178.8). 
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3.2 Socio-demographic characteristics of study participants 
The majority of study participants sampled (70%) were women. The mean age of all 
participants was 36 years (SD 8.6). The mean age of men was 40.8 years compared to 34.5 
years for women, and this difference was statistically significant (p-value <0.05). Marital status 
also differed significantly by gender with women (49%) being more likely to be single than 
men (33%) shown in Table 1. The majority of the participants have either completed primary 
or secondary school (44% and 41% respectively). There is no significant difference in 
educational qualification between men and women (Table 1).  
 
The level of employment stands at 43% for all participants while Nguni languages were 
mostly spoken as the home language at 62% and followed by Sotho languages (32%).   
 
Study participants had an average of two children (1-3) as shown in Table 1. 
Table 1: Socio-demographic characteristics of study participants  
 Men 
(N = 128) 
Women 
(N = 302) 
P-value Total  
(N = 430) 
Mean age (SD) 40.8 (8.7) 34.5 (7.8) < 0.001 36.4 (8.6) 
Age categories n (%) 
24 years and below 2 (1.6) 29 (9.6) < 0.001 31 (7.2) 
25 – 34 years 30 (23.4) 125 (41.4) 155 (36.1) 
35 – 49 years 77 (60.2) 148 (49.0) 225 (52.3) 
50 years and above 19 (14.8) 0 (0) 19 (4.4) 
Marital status n (%) 
Single 42 (32.8) 148 (49.0) 0.004 190 (4.2) 
Living together 35 (27.4) 81 (26.8) 116 (27.0) 
Married 38 (29.7) 48 (15.9) 86 (20.0) 
Divorced 7 (5.5) 9 (3.0) 16 (3.7) 
Widowed 6 (4.7) 16 (5.3) 22 (5.1) 
Education 
No schooling 17 (12.7) 26 (8.6) 0.375 43 (9.9) 
Completed primary 62 (46.3) 128 (42.5) 190 (43.7) 
Completed secondary 49 (36.6) 129 (42.9) 178 (40.9) 
Tertiary 6 (4.5) 18 (6.0) 24 (5.5) 
Currently Employed 65 (50.8) 120 (39.7) 0.034 185 (43.0) 
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Home Language 
Nguni (isiZulu, isiXhosa, isiNdebele, or siSwati) 80 (62.5) 186 (61.6) 0.930 266 (61.9) 
Sotho (seSotho, Setswana, or isiPedi) 40 (31.3) 98 (32.5) 138 (32.1) 
Others 8 (6.3) 18 (6.0) 26 (6.0) 
Mean number of own children (SD) 2.3 (1.6) 1.9 (1.4) 0.0129 2.0 (1.4) 
 
3.3 HIV Diagnosis, Disclosure and Treatment 
3.3.1 Duration since HIV diagnosis  
Most participants (79.5%) have known about their HIV status for more than a year, with 9% 
finding out about their HIV status in the preceding six months (Figure 4). The duration since 
HIV diagnosis was not significantly different (P-value=0.969) between men and women (figure 
3) 
Figure 3: Duration since HIV diagnosis     
3.3.2 HIV Disclosure 
The majority of participants indicated that they had disclosed their HIV status (95%). There 
was no significant difference in HIV disclosure by gender: 97% in men and 94% in women (p-
value = 0.232).  
 
More women (71%) compared to men (54%) had disclosed their HIV status to family members; 
while more men (33%) compared to women (16%) disclosed their status to their partner (Table 
2). These differences were statistically significant (p-value<0.001).  
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Only 9% of study participants reported that they were living openly with HIV, with more men 
(12%) in this category. 
 
Table 2: HIV disclosure 
 Men Women P-value Total 
HIV disclosure n (%) 
No 4 (3.2) 18 (6.0)  22 (5.2) 
Yes 122 (96.8) 283 (94.0) 405 (94.9) 
To whom disclosed n (%) 
Own family member only 66 (54.1) 200 (70.7) < 0.001 266 (65.7) 
Partner only 40 (32.8) 45 (15.9) 85 (21.0) 
Living openly with HIV 15 (12.3) 23 (8.1) 38 (9.4) 
Others 1 (0.8) 15 (5.3) 16 (4.0) 
 3.3.3 Antiretroviral treatment 
Most participants (93%) were on antiretroviral treatment (HAART), although this differed 
significantly by gender (p-value=0.018). Men (97.6%) were more likely to be on HAART than 
women (91.3%). Among those on HAART, there were no significant gender differences in the 
duration on ART (Table 3), with 19% of participants being on ART for more than five years.  
 
 
 
 
 
 
 
 Men 
(N = 128) 
Women 
(N =302) 
P-value Total 
(N = 430) 
Currently on HAART n (%) 124 (97.6) 274 (91.3) 0.018 398 (93.2) 
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Table 3:  HAART and Duration 
 
3.3.4 Current Health Status  
Overall, most participants (77%) described their current health status as good or excellent. Only 
4% perceived their health to be poor. Perceived differences in health status by gender were not 
statistically significant (Figure 4). 
 
Figure 4: Participants’ perception of their health status  
 3.3.5 Experience of discrimination 
The majority of participants (Table 4) reported no experience of discrimination (83%) 
However, women were twice more likely to report experience of some forms of discrimination 
(20%) compared to men (9.5%) (p-value=0.008). 
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Less than a year 31 (25.4) 58 (21.1) 0.777 89 (22.4) 
One year to less than three years 35 (28.7) 78 (28.4) 113 (28.5) 
Three years to less than five year 34 (27.9) 86 (21.3) 120 (30.2) 
Five years and above 22 (18.0) 53 (19.3) 75 (18.9) 
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 Table 4: Participants’ experiences of discrimination  
 Men 
(N = 128) 
Women 
(N = 302) 
P-value Total 
(N = 430) 
Experience of discrimination n (%) 
No 114 (90.5) 240 (80.0) 0.008 
 
354 (83.1) 
Yes 12 (9.5) 60 (20.0) 72 (16.9) 
 
3.4 Sexual Behaviour 
3.4.1 Sexual partnerships and condom use 
The majority of participants reported only one sexual partner (76%). However, significantly 
more men (10.3%) compared to women (4.3%) reported having more than one current sexual 
partner (Table 5). 
 
On the frequency of condom use in the past year, 60% of participants reported being consistent 
condom users. Men were more likely to be consistent users (73%) compared to women (55. 
%), and 9% of women participants reported no condom use in the preceding year. 
 
 
 
 
 
 
 
 
  Table 5: Participants’ sexual relationship and condom usage 
 Men 
(N = 128) 
Women 
(N = 302) 
P-value Total 
(N = 430) 
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Current sexual partnership n (%) 
Not having sex 15 (11.7) 63 (20.9) 0.01 78 (18.2) 
One sexual partner 98 (77) 226 (74.8) 324 (75.4) 
More than one sexual partner 13 (10.2) 13 (4.3) 26 (6.1) 
Frequency of condom use n (%) 
Never 2 (1.6) 26 (8.6) < 0.001 28 (7.0) 
Sometimes 27 (21.1) 74 (25.0) 101 (23.5) 
Always 83 (65.0) 157 (52.0) 240 (56.0) 
 
3.5 Reproductive Choices 
3.5.1 Reproductive desire and contraception use 
Among study participants, 46% (95% CI: 41.4 – 50.9) expressed a desire to have children in 
the future, while 44% indicated that they do not wish to have children in the future.  There 
were no significant differences in reproductive desire by gender (p-value = 0.582), although a 
slightly higher proportion of men (50%) than women (44%) wished to have children in the 
future (Table 6). 
Table 6: Reproductive desire  
 
  
 
Although 189 respondents (Table 6) indicated that they did not wish to have children in the 
future, only 71 reported the use of contraceptives. The injection was the most common form of 
contraception (60%). 
 Men 
(N = 128) 
Women 
(N = 302) 
P-value Total 
(N = 430) 
Wish to have children in future n (%) 
No 52 (41.3) 137 (45.5) 0.582 189 (44.3) 
Yes 63 (50.0) 134 (44.5) 197 (46.1) 
Unsure 11 (8.7) 30 (10.0) 41 (9.6) 
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Figure 5: Types of contraception used 
3.5.2 Reasons for not wanting children 
Participants’ reasons for not wanting to have children included: already having children (54%); 
lack of money to care for another child (12%), while the least common reason was stigma and 
the reproductive desires of partner (Figure 6). A breakdown of these reasons by gender showed 
that men were more likely than women to say that they already have children: 64% and 50% 
respectively. However, women (15%) were more likely than men (3%) to indicate the lack of 
money to care for another child as a reason for not wanting children.  
 
Figure 6: Reasons given by participants for not wanting children. 
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3.5.3 Reasons for wanting children 
Reasons given by participants for wanting children were several and the commonest were 
wanting more children (36%) and ‘I do not have any child of my own’ (22%).  
 
Figure 7: Reported reasons for wanting children 
 
3.5.4 Reproductive options 
The majority of the participants (55%) indicated that they will wait for the doctors’ advice on 
the appropriate fertility option and 20% of the respondents were in favour of the natural method 
of conception. Participants who expressed a desire for artificial insemination made up 10% 
while those who are not certain about the reproductive options available to them were 13% 
(Figure 8). 
 
Figure 8: Reproductive options 
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3.6 Factors influencing reproductive desires 
Reproductive desire was dichotomised as yes and no. The 41 respondents (10%) who reported 
being unsure were excluded from the analysis. The final analysis therefore included the 197 
respondents who answered ‘yes’ and the 189 who answered ‘no’.  The explanatory variables 
considered and reported below are gender, age, marital status, and home language, number of 
children, educational level, employment, and HIV disclosure status, antiretroviral therapy, 
health status, duration on ART and experience of discrimination (Table 7). 
3.6.1 Gender  
Although more males (55%) than females (50%) indicated the desire to have children in the 
future, the difference was not statistically significant. 
3.6.2 Age  
As age increased the desire to have children decreased significantly (p-value < 0.01), with 80% 
of those younger than 25 years indicating the desire to have children.  
3.6.3 Marital status 
Marital status was also associated with the desire to have children (p<0.01). Those who were 
divorced or widowed (29%), as well as those who were married (45%), were less likely to have 
the desire to have children than those who described themselves as single (50%) or living 
together (65%). 
3.6.4 Home language 
There was no significant association (p=0.576) between home language and desire to have 
children.  
3.6.5 Number of children 
The majority of participants with no children (90%) expressed the desire to have children in 
the future as compared to those who have two or more children (38%). This difference was 
statistically significant (P<0.01). 
3.6.6 Education 
Education was also associated with reproductive desire (p<0.01). The higher the level of 
education, the higher was reproductive desire. While about 60% of those with tertiary 
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qualification expressed the desire to have children in the future, only 27% of those with less 
than primary education desired to children in future. 
3.6.7 Currently employed 
There was no significant association between being employed and wanting to have children in 
the future (p=0.566). 
3.6.8 HIV status disclosure 
Although respondents who had disclosed their HIV status were more likely to express desire 
to have children (51%), the difference was not statistically significant (p-value=0.589).   
3.6.9 Antiretroviral therapy 
Being on antiretroviral therapy was not associated (p-value = 0.574) with the desire to have 
children in the future. 
3.6.10 Duration on ART 
The percentage of respondents who expressed a desire for children increased as the duration 
on ART increased (p-value=0.104).   
3.6.11 Health status 
Perceived health status was significantly associated with desire to have children (p-value=0.04) 
in the future. Those who described their health as good or excellent (54%) were more likely to 
express reproductive desire than those who described their health as poor or okay.  
3.6.12 Experience of HIV discrimination 
There was no association between experience of discrimination due to HIV status and the desire 
to have children in the future (p-value=0.631). 
Table 7: Associations of reproductive desire with socio-demographic and other variables  
 N % P-value 
Gender 0.337 
Male 115 54.8 
Female 271 49.5 
Age < 0.01 
less than 24years 25 80 
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25-34 years 136 66.18 
35-34 years 208 41.35 
Home language  
Nguni  241 48.96 0.576 
Sotho 123 54.47 
Other 22 54.6 
Marital status < 0.01 
Single 167 49.70 
Living together 105 64.76 
Married 80 45 
Divorced/widowed 34 29.41 
Number of children < 0.01 
None 52 90.38 
one 97 77.32 
2-3 178 37.64 
Four and above 59 13.56 
Highest educational qualification < 0.01 
Less than primary 37 27 
Completed primary 164 48.17 
completed secondary 160 58.13 
Tertiary 22 59 
Employment 0.566 
unemployed 221 49.77 
Employed 165 52.73 
HIV disclosure  
Have not disclosed 18 44.4 0.589 
Have disclosed 365 50.7 
On antiretroviral therapy 0.574 
No 21 57.14 
Yes 362 50.83 
Duration on ART 0.104 
Less than a year 79 54.43 
One year to less than three years 106 58.49 
Three years to less than five years 107 46.73 
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3.6.2 Factors influencing reproductive desire 
Of the 12 explanatory variables analysed, five were significantly associated with reproductive 
desire at p-value<0.05. These factors were: younger age, married or living together, no own 
children, higher educational qualification and good or excellent health status.  All five variables 
were considered for inclusion in the multivariate model.  Three were independently associated 
with the outcome (i.e. reproductive desire). These three variables were: age below 49 years 
{35-49 years (AOR=11.8; 95% CI: 1.3 – 107), 25-34 years (AOR=28.1; 95% CI: 3.0-265),  
below 25 years (AOR=22.0; 95% CI: 1.9-254)},  being married (AOR=3.0; 95% CI: 1.0 – 
8.6) or living together (AOR=3.7; 95% CI: 1.3 – 10.6) and having no child (AOR=51.5; 95% 
CI: 14.8–178.8), are the independent explanatory variables associated with reproductive 
desires (Table 8).  
Table 8:  Multivariate logistic regression of factors influencing reproductive desire (=outcome)  
Five years and above 68 41.18 
Health status 0.04 
Poor/Okay 91 41.76 
Good/Excellent 292 54.11 
Experienced HIV discrimination 0.631 
No 317 51.74 
Yes 66 48.48 
 Unadjusted OR  
(95% CI) 
Adjusted OR 
 (95% CI) 
P-value 
(AOR) 
Age group 
50 years and above 1 1  
35 to 49 years 11.3 (1.5 – 87) 11.8 (1.3 – 107) 0.029 
25 to 34 years 31.3 (4.0 – 243) 28.1 (3.0 – 265) 0.003 
Less than 24 years 64.0 (6.8 – 604) 22.0 (1.9 – 254) 0.014 
Marital status 
Divorced/Widowed  1 1  
Married  2.0 (0.8 – 4.6) 3.0 (1.0 – 8.6) 0.046 
Living together 4.4 (1.9 – 10.2) 3.7 (1.3 – 10.6) 0.014 
Single 2.4 (1.1 – 5.3) 1.3 (0.5 – 3.7) 0.571 
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3.7 HIV Services at PHC facilities 
Table 9 shows the various HIV or related services received at the PHC facilities.  
3.7.1 Participants requesting information on reproductive health at the clinic 
The participants who had requested information from a doctor or a nurse in the preceding year 
on ways of having a baby were 21%. 
3.7.2 Information / counselling sessions provided  
The majority of participants indicated attendance at counselling sessions on how to lower the 
risk of HIV transmission and having a baby while on ART (88% and 76% respectively) while 
only 38% attended sessions on different ways of having a baby when one is HIV positive. 
3.7.2 Desired topics for counselling sessions by participants 
The majority of participants (86%) expressed an interest in counselling sessions on sexual 
relationships; 72% indicated interest in attending a session on how PLHIV can have children 
while 75% preferred a session on family planning. 
 
 
 
 
 
No of children 
Four and above  1 1  
Two to three 3.8 (1.7 – 8.6) 3.1 (1.4 – 7.2) <0.01 
One 21.7 (9.0 – 52.6) 22.0 (8.4 – 57.4) <0.01 
None 60.0 (18.3 – 196.1) 51.5 (14.8 – 178.8) <0.01 
Highest qualification 
Less than primary 1 *  
Completed primary 2.5 (1.1 – 5.5) * 
Completed secondary 3.7 (1.7 – 8.3) * 
Tertiary 3.9 (1.3 – 11.9) * 
Health status 
Poor/Okay 1 *  
Good/Excellent 1.6 (1.0 – 2.6) * 
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Table 9: HIV or related services received at PHC facilities 
 Men 
(n = 128) 
Women 
(n = 302) 
P-value Total 
(n = 430) 
Participants requesting information from health staff 
Has talked to a doctor or nurse about having a 
baby in the past 12 months 
37 (29.4) 50 (16.7) 0.003    87 (20.5) 
Information  or counselling sessions  
 
Attended session on family planning or 
contraception for People Living with HIV 
40 (32.3) 154 (51.3) <0.01 194 (45.8) 
Attended session on counselling on how to lower 
the risk of transmitting HIV to others 
106 (82.8) 272 (90.4) 0.027 378 (88.1) 
Attended session on  prevention of mother-to-
child transmission of HIV 
76 (61.3) 187 (62.5) 0.809 263 (62.2) 
Attended session on different ways of having a 
baby when one is HIV positive 
60 (47.2) 101 (33.8) 0.009 161 (37.8) 
Attended session on ART and having a baby 
(PMCT) 
69 (54.8) 252 (84.6) <0.01 321 (75.7) 
Desired topics of counselling sessions by participants 
 
Would be interested in attending a session on 
sexual relationships for PLHIV 
110 (86.6) 258 (86.3) 0.928 368 (86.4) 
Would be interested in attending a session on 
family planning or contraceptives for PLHIV 
103 (83.1) 212 (70.9) 0.009 315 (74.5) 
Would be interested in attending a session on how 
PLHIV can have a child/ children 
108 (85.0) 195 (65.7) <0.01 303 (71.5) 
 
3.8 Preferred Setting for Sessions on Reproductive Health  
When asked about the preferred setting respondents would prefer to receive reproductive health 
information, the majority chose a seminar or workshop. There were no gender differences    
observed in the responses (p-value <0.388), shown in Figure 9. 
 
Figure 9: Preferred setting for reproductive health information 
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CHAPTER 4: DISCUSSION  
4.1 Introduction 
This research study explored reproductive choices among HIV positive patients attending PHC 
clinics in Ekurhuleni district, the factors influencing their desires, their knowledge of available 
reproductive options and the reproductive health services received at these clinics. This is one 
of the first studies that examined an aspect of sexual and reproductive health of PLHIV in the 
Ekurhuleni district in Gauteng Province.   
In this chapter, the findings of the study are discussed in light of the study objectives and the 
existing literature on the topic. 
4.1.1 Socio demographic characteristics 
The majority of the participants were 25-49 years of age,  thus confirming existing evidence 
that HIV primarily affects the economically active section of the population (6, 11). Hence, the 
importance of addressing the sexual and reproductive health needs of this sub-group of the 
population.  
Sadly, but not surprisingly, there were high levels of unemployment, which implies dependence 
on the public health facilities (30, 32). Hence, the importance of addressing the sexual and 
reproductive health needs of PLHIV, particularly in the public health sector. 
4.1.2 HIV Diagnosis, Disclosure and Treatment 
Encouragingly, the majority of participants were on ARV (93%), showing very good retention 
and coverage of the large HIV management programme of the South Africa government (130). 
More men (98%) than women (91%) were on treatment in contrast to other studies where 
higher proportions of women were on ARVs than men. Muula et al found in a systematic 
review that in most Southern African countries, there were more females accessing HAART 
than males which cannot be explained by the higher HIV prevalence among females compared 
to males (131). The situation was found to be similar in other studies (132-135). 
This could be due to the efficient and effectiveness of the initiation and treatment programme 
provided in most PHC facilities in the district. 
This study found that there was a low level of disclosure of HIV status to sexual partners by 
participants, with only 16% of women reporting disclosure to their sexual partners.  The finding 
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is similar to the study by Simbayi et al, 2006, in Cape Town, where 42% of participants had 
not disclosed their HIV status to their sexual partners (136). Another South African study done 
by Olley et al also found that 78% of participants had not disclosed their HIV status to their 
sexual partners (137). Others studies also reported similar findings (138-141). This study 
finding is worrisome from the stand point of transmission of HIV infection and the difficulty 
it might pose for HIV positive sexual partners seeking reproductive assistance.  
This study found that most participants (83%) had not experienced any form of discrimination 
which is an improvement when compared with the high level of stigma reported about the 
experiences of HIV positive patients at the onset of the disease epidemic (132-135). However, 
only a small proportion of the participants (9%) indicated that they were ‘living openly’ with 
HIV and this may explain the reportedly low level of discrimination experiences. A study done 
by Simbayi et al in 2007, reported that 40% of the study participants in Cape Town reported 
discrimination on the basis of HIV positive status (142). As the primary focus of the study was 
not on experiences of stigma and discrimination, the exact level of stigma would require further 
investigation to determine whether and how it affects attitudes towards sexual and reproductive 
choices and rights of PLHIV. 
 
4.2 Reproductive Desires among Participants 
In this study 50% of men and 44% of women expressed a desire to have children.  This 
expressed desire for children is similar to other studies. Cooper et al also found that in Cape 
Town, 55% of female and 43% of male participants in their study wanted children (143). 
Similarly Beyeza-Kashesya et al, 2010 also found that 64% of female and 55% of male HIV 
positive participants expressed the desire for children (69). Rispel et al also found that the 
desire to have children was high amongst HIV-discordant couples interviewed in South Africa 
and Tanzania (70). Chen et al reported similar high rates in their study of fertility desires and 
intentions of PLHIV in the United States of America (60). Oladapo et al also reported a high 
expressed desire for children in their study in Nigeria (144). 
 
Numerous studies have found that the desire for children among Africans is higher, compared 
to non-Africans (145, 146). Heard et al, reported that men and women of African ethnicity 
living in France expressed desire for children was three times higher compared to  Europeans 
(147). This was attributed to the socio-cultural background of people of African origin: for 
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women, motherhood is considered as a high social status and identity, and as a prestige among 
peers while for men, on the other hand, fatherhood is critical as it ensures the continuation of 
the family name and lineage (42, 62, 64, 66, 68, 148, 149). In this study, the population was 
homogeneous and ethnicity was not a considered a variable.  
 
Interestingly, although this study was conducted at a time when levels of HIV&AIDS 
knowledge are high, the study findings suggest that there have not been much change with 
regards to the desire for children among PLHIV. Hence, reproductive health services for HIV 
patients are even more relevant and important in the current context. 
 
4.3 Factors influencing reproductive choices of HIV positive patients 
In this study, the multi-variate analysis found that age below 49 years, being married or living 
together; and having no child were the predictors of reproductive desire (Table 8).  
 
The study found that at age younger than 25 years of age, 80% of respondents expressed the 
desire for children, compared to 6% at age 50 years and above. These research findings are 
similar to those of other research studies (42, 62, 64, 66, 68, 148, 149). Oladapo et al, found 
that the reason that younger HIV positive patients had a greater desire for children, was the 
socio-cultural pressure on young adults for fulfillment because of  the fear of dying early from 
the disease (144). 
 
Marriage or living together was also found to be one of the predictors of the desire for children. 
This may imply stability in a relationship and thus increase the desire for wanting children.   
However, the desire for children decreased among participants with more than one child 
compared to those with none, so these factors have to be looked at in combination. The inverse 
relationship between number of children and desire for children was reported by Cooper et al 
and Chen et al (60, 143).  
A further, argument could be advanced that those in marriage or living together might be of 
advanced age and/or having many children already and consequently may not desire more 
children. On the other hand married couples might view the main outcome of marriage as 
having children and so will their desire to have children despite their HIV status. The 
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explanation for the increased desire for children among PLHIV who are either married or living 
together as independent variable observed in this study cannot be easily explained. Further 
research may be necessary to determine which of these variables are more strongly correlated 
to reproductive desires. 
This study did not find self-reported health status or being on HAART to be a predictor of 
reproductive desire. This contrasts with other research findings (63,68,150). In the study by 
Oladapo et al, ill-health due to advancing HIV infection, evidenced by low CD4 count, was 
found to be an independent predictor of fertility desire (144). The socio-cultural fulfilment of 
child bearing made very sick individuals want to have children before dying (144). 
 
In this study 44% of participants indicated that they do not want to have children. Among the 
reasons given by participants for not wanting  children were:  already had own children,  lack 
of enough money to care for another child,  fear of a baby being born with HIV infection, old 
age and lack of a stable partner. However, among those not desiring children only 36% reported 
contraceptive use. This may mean that they are not entirely against having children or that male 
respondents were not sure of the use of contraception by their female partners. It could also 
mean that condoms were used as the main method of contraception. 
 
4.4 The Knowledge of HIV Positive Patients on Reproductive Options 
Most of the respondents who expressed a desire to have children were in favour of the natural 
method of reproduction (20%). This could be that the natural method is the only one known by 
the majority of participants. Although natural reproduction is recommended for PLHIV 
especially HIV sero-discordant couples, there are specific requirements and guidelines which 
may not be understood by PLHIV (151). Hence, the research participants favouring natural 
methods may need guidance on the most appropriate method. 
 
Thirteen present of respondents did not know the various types of reproductive options 
available. This lack of knowledge of PLHIV on fertility options limits their ability to make 
informed reproductive decisions. It could be due to lack of information on reproductive issues 
among these PLHIV. The knowledge of available reproductive options by PLHIV has not being 
a focus of most research studies; hence this finding cannot be compared with the findings of 
other studies.  
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Most of the respondents (55%) wanted guidance from the medical personnel on the appropriate 
reproductive options available to them. This could be due to many participants’ lack of 
knowledge about other options such as artificial insemination and assisted reproductive 
technologies (ART).  In the context where ART services are not included in the reproductive 
services, it is unlikely that patients will be informed about them as has been reported in Latin 
American countries (107), Vietnam (106) and Kenya (105). In several instances the inadequacy 
on the part of HCWs on the provision of reproductive services and negative attitudes of HCW 
towards PLHIV on sexual and reproductive health made it difficult to meet the needs of their 
patients (93, 152). 
The possibility of adoption was not explored in our study but it would be interesting to 
understand how the situation in Ekurhuleni compares with the negative attitude towards 
adoption found in Cape Town (143). 
 
4.5 Reproductive Services Offered At PHC facilities 
In our study, although the PLHIV interviewed expressed their reproductive desires, they were 
not engaging the HCWs at the clinics about the necessary information on reproductive services. 
Only 21% of respondents who expressed the desire for children had requested information 
about it in the preceding year. This could mean that the staff may not be approachable or 
receptive to such discussions. Some research findings cited negative HCW attitudes towards 
child-bearing by PLHIV.  Equally too, it could be due to poor or lack of coordination of services 
at the clinics (83,153,154). Harries et al reported in their study in Cape Town, South Africa, 
that research respondents cited systems problems as a hindrance to the provision of health care 
services to all patients including PLHIV (153). 
 
Lacks of confidence in health workers ability to address the needs on reproductive options were 
also expressed by patients in another study (155).  In other research reports, it was shown that 
health workers as well as PLHIV were uncertain about the reproductive rights of PLHIV (62, 
98-100). 
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This study found that counselling was readily provided on family planning and prevention of 
HIV transmissions (including PMTCT) for 88% of patients, but only a few counselling sessions 
on reproductive options for PLHIV were organised and attended by respondents (38%) in the 
preceding year. Inadequate information on reproduction options was also reported by Sherr et 
al (62). The deduction is that there are probably no clear directives or established programmes 
by the health authorities on SRH for PLHIV as all service provision at the public clinics are 
guided by and monitored through the provision of government health policies.  
 
As part of this study, participants were requested to indicate the setting for training or 
information on reproduction for PLHIV. The majority of participants preferred to receive 
information through seminars or workshops in men’s or women’s groupings. This is an 
important and relevant finding as the practice has been that counselling on any issue about 
sexual and reproductive care for HIV patients should be done on an individual basis in the 
private venue or room to maintain confidentiality. A further enquiry to establish the rationale 
for this choice will shed more light on the issue as it is crucial in tailoring the provision of 
services in this regards. This finding is novel as no research study could be found that examined 
this aspect of service provision. 
 
4.6 Study Strength and Limitations  
This was a cross-sectional study carried out in a resource limited district in Gauteng province, 
and the findings cannot be generalised to all districts in South Africa, except those with similar 
features to Ekurhuleni. 
 
The wide confidence interval in the analysed data indicates inadequate statistical power.  
Although more than 400 patients participated in the study, a much bigger sample would be 
needed. 
 
The respondents in this research were those who attended the public clinics for care and 
treatment and therefore their responses may differ from those attending private facilities or 
general practitioners. The study relied on self-reported information from PLHIV in a health 
care setting. Hence there may be social desirability bias, as respondents may have been 
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concerned about possible victimisation or negative consequences for subsequent care at the 
clinics. However, considerable efforts were made to use trained fieldworkers, and not the staff 
that provide care at these facilities where the study was conducted. All participants were given 
clear information and assured of their privacy and confidentiality during and after the 
interviews. 
 
There are numerous strengths of this research study.  This was one of the first studies to 
examine various aspects of sexual and reproductive health issues of HIV positive patients at a 
PHC level in Ekurhuleni district. A 100% response rate was obtained, and collecting date via 
face to face interviews ensured that the views of PLHIV who are not literate were elicited. This 
study also determined the preferred setting for information sharing and counselling on 
reproductive desires, an element hitherto unexplored in other studies on SRH and PLHIV. The 
study provides valuable information for programme or service planning, which is important in 
light of the much longer survival of PLHIV because of life-saving ARV treatment.  
 
4.7 Conclusion 
The study found that there is expressed desire for children among PLHIV, their knowledge on 
the available reproductive options was limited and the demand for such services was found to 
be low. However, the participants expressed desire to be informed about reproductive options 
was high. The sexual and reproductive services offered at the PHC facilities reported by 
participants was mainly counselling on prevention of HIV transmission particularly PMTCT 
and as well as family planning. The respondents in this study indicated preference for men or 
women group discussions on reproductive health information. The final chapter focuses on the 
recommendations, based on the findings of the study. 
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CHAPTER 5: CONCLUSIONS AND RECOMMENDATIONS 
5.1 Introduction 
Using a cross-sectional study design, this study sought to investigate the reproductive choices 
of HIV positive patients in Ekurhuleni district, Gauteng Province. The study generated locally, 
context specific information on the: choices of HIV patients with regards to reproduction and 
the motivating factors for these choices; PLHIV’s knowledge of fertility options and services 
available to them at the PHC facilities in Ekurhuleni area were also elicited.  The key results 
of the study were presented and discussed in the previous chapters. The study findings 
accentuate the need for the provision of reproductive health services that are responsive, of 
high quality and that are provided within a human rights framework.  
  
There are encouraging developments within  South Africa:  the revised national strategic plan 
(NSP) for HIV, overseen by the South African National AIDS Council (SANAC), provides 
guidance on interventions and activities that will change the incidence and prevalence of HIV, 
STIs and TB (130). 
 
One of the NSP objectives; Prevent New HIV infections, has a sub-objective that requires the 
integration of sexual and reproductive health services into the larger PHC programmes. The 
main areas addressed in the sexual and reproductive package of service include medical male 
circumcision, provision of male and female condoms, contraception, screening and treatment 
for cervical cancer. However, there are no clear guidelines on reproductive health services that 
will motivate the provinces and districts to ensure comprehensive services are established for 
the reproductive health needs of PLHIV. The NSP falls short of the policy position required to 
respond to the  sexual and reproductive services needs of PLHIV (130). 
 
5.2 Recommendations 
As a consequence of this research study, the recommendations are listed in box 2 below. 
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Box 2: Summary of Recommendations 
SUMMARY OF RECOMMEDATIONS 
SHORT TERM RECOMMENDATIONS 
Clinic services 
 Reproductive health service such as counselling on fertility options should be offered at the 
PHC facilities.  
 Sexual and reproductive health service guideline / protocols should be made available to 
HCWs.  
 Dedicated sessions should be organised in men’s or women’s groups for education on 
reproduction services for HIV positive patients.  
 The clinics should be equipped with educational and demonstration tools to educate PLHIV 
such as equipment and audio-visual materials.  
 
Health care workers at PHC facilities 
 All health professionals (doctors, nurses, etc.) should receive training on the reproductive 
needs and rights of PLHIV and the provision of SRH services.  
 
Hospital services 
 Dedicated centres should be established for assisted reproductive technology (ART) services 
for PLHIV.                                                                               
 
BROAD RECOMMENDATIONS 
National policy  
 The South National AIDS council (SANAC) strategic policy document should address sexual 
and reproductive health services for PLHIV.  
Provincial and District Health policies 
 Similarly, provincial and district health plans should address the reproductive needs of HIV 
positive patients. 
 
5.2.1 Short term recommendations 
Clinic services 
Reproductive health service such as counselling on reproductive options and ART should be 
offered at the PHC facilities across the district at the level determined by resources and 
capacity. 
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Sexual and reproductive health service guideline/protocols on reproductive option should be 
made available to HCWs and visibly displayed at the consulting rooms in the clinics where 
services are provided for easy reference.  Dedicated sessions should be organised in male or 
female groups for education on reproduction services for HIV patients at the clinics. 
Appointments with HCWs to discuss any concerns by PLHIV should be made possible.  The 
clinics should be equipped with educational and demonstration tools and audio-visual materials 
and equipment to educate PLHIV.  
 
Health care workers at PHC facilities 
All health professionals (doctors and nurses, and other categories)  should receive training on 
the reproductive needs and rights of PLHIV in other to improve their capacity to provide this 
service and they should be sensitised perhaps through value clarification workshops to  change 
their attitudes towards the SRH needs of HIV positive patients (62). All health professionals 
should have access to appropriate guidelines and  protocols that enable them to meet the 
required needs of all HIV positive patients (156).  
 
The HCWs at the clinics should be taught about informed consent to ensure that proper consent 
is obtained before any procedure is attempted. The doctors and PHC nurses should be trained 
to provide and teach self-insemination of semen for HIV discordant couples and partners where 
the male is HIV negative. This will require a mind-shift as well as careful changed management 
processes. 
 
Hospital services 
Dedicated centres should be established in each sub-districts in a level two or three hospitals 
(provincial or academic hospitals) for assisted reproductive technology (ART) services for 
PLHIV especially for discordant couple or partners, were the female is HIV positive and also 
where viral load could not be suppressed to undetectable level among HIV positive partners.  
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5.2.2 Broad recommendations 
National policy  
          SANAC should revise strategic policy documents to include specific goals, objectives, and       
          outcome measures for the sexual and reproductive health services for PLHIV.  
 
Provincial and district health policies 
               Similarly, provincial and district health plans should address the reproductive needs of HIV     
               positive patients in line with SANAC strategic plan.   
 
Conclusion 
South Africa has been the leader in the provision of government funded ARV treatment 
programmes, and to provide these services in an affordable manner. The recommendations 
based on the study findings are realistic and could be achieved with stewardship and leadership 
at all levels of the health system.  
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Appendix 2: Participant information sheet 
 
TITLE: REPRODUCTIVE CHOICES AMONG HIV POSITIVE PATIENTS IN EKURHULENI 
DISTRICT, GAUTENG PROVINCE 
Participant information sheet  
Introduction  
Good morning. My name is ……………………………………….... I am assisting Dr Samuel Agbo with 
a study on Reproductive choices among HIV positive patients in Ekurhuleni district, Gauteng province. 
The study is being done for a master’s degree. 
Why are we doing the study?  
The purpose of the study is to learn about reproductive choices of HIV positive people and the reasons 
why they make these choices. We also want to find out about the reproductive services that are available 
at the clinics. We hope that the information obtained from the study will be used to assist with the 
improvement of existing services in the district. 
 How we will do the study? 
As part of this study we want to get the perspectives of people living with HIV on the reproductive 
choices they make and some of the reasons for their choices. We also want to find out about available 
services at this clinic. 
In every selected health centre, we are asking around 150 patients for their views. You were selected by 
chance and no staff member or anyone else said we should talk to you. We would like to ask you a few 
questions.  It should take 25 minutes for you to answer the questions. I will be happy to go through the 
questions with you if you agree.  
Many of these questions will be of a personal nature, including questions about your HIV disclosure and 
your relationships.  
Our role is to listen and to understand your view points, but not to pass judgment. It is your views and 
opinions that are important.  There is no right or wrong answers.  How you answer the questions will 
not affect the care that you yourself receive in this health centre positively or negatively, and we will not 
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tell the nursing staff what you say to us.  We will incorporate your answers, anonymously, into an 
overall report.  
We cannot help you with any complaints that you have with your nursing care at the clinic and we 
cannot tell the nursing staff if you are really happy with their services.  
How do I know that the information I give will be kept confidential? 
This interview will take place in a private room between you and me. The information that you provide 
will be kept confidential and will be used for the purpose of this study only.  Everything that you say will 
be treated as private and confidential.  I will complete the questionnaire with the answers that you give, 
but I will not disclose your name or any other information that could be used to identify you.  This means 
that no other person apart from me and the researcher will know that you took part in the study, or know 
how you answered the questions.  Your HIV status will not be disclosed to anyone else.   
The answers given by you and other participants will be analysed and combined, and the combined 
information will be written-up in a form of a report.  In the report people who took part in the research 
may be given false names, but their real names won’t be used.  The name of the province and townships 
where participants live may be mentioned, but the names of participants will not be used in any report. 
Did you get permission to carry out the study? 
Permission to carry out this project was obtained from the University of the Witwatersrand Research 
Ethics Committees. The health department has also approved the study. 
We will appreciate your participation and we will ask you to sign an informed consent form to participate 
in the study.  
 Will there be any benefits from participating? 
There will be no direct benefits to anyone who participates in the interviews as participation is voluntary. 
This means you have the right to refuse to answer the questionnaire or if you do agree to answer the 
questionnaire you can leave out the answers you are uncomfortable with and you can stop the interview 
at any time.  
Will there be any harm from participating? 
Some of the questions are of a personal or sensitive nature and you may feel uncomfortable in answering 
them.  Other than the possible discomfort of answering some questions and the possible inconvenience of 
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taking up your time to interview you, we don’t foresee any risks or negative consequences to you taking 
part in the research. If you feel upset during the interview, we can stop the interview at any time. We will 
arrange for you to see a counsellor at the clinic. If the counsellor in the clinic is not available you will 
be referred to a counsellor in the nearest clinic or hospital 
If you do not want to be interviewed, there will be no negative consequences. However, we would really 
appreciate it if you do share your thoughts and feelings about the questions we will be asking you. We 
hope that the information we will get from you will be used to inform or advocate for health service 
improvements.  
Who do I contact if I want to ask more questions?  
We will be happy to answer any questions you have about this study. This research has been approved by 
the University of the Witwatersrand Research Ethics Committee.  If you have any questions about your 
rights as a study participant, or questions or concerns about any aspect of the study, you may contact the 
ethics office on (011) 717 1234. If you have questions about the research, you may also contact the 
principal investigator:  
Dr Sam Agbo 
Phone: +27 11-8788548.  
 Email:samnoja@mweb.co.za 
 
Thank you. 
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Appendix 3: Informed consent form 
 
TITLE: REPRODUCTIVE CHOICES AMONG HIV POSITIVE PATIENTS IN EKURHULENI 
DISTRICT, GAUTENG PROVINCE 
CONSENT FORM 
The study has been explained to me and I have had a chance to ask questions and have them answered 
to my satisfaction. I have freely chosen to take part. I am aware that I can change my mind about taking 
part at any time and stop the interview without any penalty. I have been told that agreeing to the 
interview will not be of any direct personal benefit to me. I have been told that my answers to questions 
will remain confidential and that this consent form will not be linked to the answers I give. 
I have been given telephone numbers that I may call if I have any questions or concerns about the 
research. 
 
------------------------------------------       -----------------------------------------           ---------------------------- 
Participants Name (Print)                 Participant’s signature                                   Date: 
------------------------------                                              -------------------------------------                         
Interviewer’s Name                                                        Interviewer’s signature                           Date 
 
If verbal consent is provided, the interviewer must sign below in the presence of the participant and a 
witness.  
--------------------------------------------------                        Date ------------------------------------------ 
Signature of interviewer certifying that informed consent has been given verbally by the participant. 
____________________                                        Date:   __________________________ 
Signature of witness certifying that informed consent has been given verbally by the participant.  
 
Statement on Behalf of the Researcher 
I _______________________________________, declare that I have explained the  
            (Interviewer’s name) 
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information given in this document to _________________________________    
                                                 (Participant’s name) 
He / She has been given the opportunity to ask me questions about the study and to have his / her 
questions answered.  
The interview was conducted in English/Other language (specify language) __________________ and 
no translator was used. 
Signed at      ___________________________ on   _______________________                                             
(Place)             (Date) 
Signature of interviewer: ______________________________________ 
Signature of witness: ________________________________________ 
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Appendix 4: Questionnaire 
REPRODUCTIVE CHOICES AMONG HIV POSITIVE PATIENTS IN EKURHULENI 
DISTRICT, GAUTENG PROVINCE. 
Questionnaire 
For official use only 
1. 2 Sub-district  O ESDR   1 
O SSDR   2 
O NSDR   3 
 
2.  Health Facility ID 
  
   
 
3. 3 Participant number   
 
    
 
4. 8 
Date of interview:   DD/MM/YY  
      
 
5. 1
2 
Was the interview 
completed? 
O No   0 
O Yes   1 
 
 
 
6. 1
5 
Date checked: DD/MM/YY  
      
 
 
SECTION 1: BACKGROUND CHARACTERISTICS  
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For official 
use only 
  
 
  
 
101 How old are you? (in completed years) 
______   years  
 
 
 
102 Gender  
 Male…1 
 Female…2 
 
 
 
103 What is the main language that you speak 
at home? 
O English…1 
O isiZulu, isiXhosa, isiNdebele, or  
siSwati…2 
O seSotho, Setswana, or sePedi…3 
O Other…9 
 
 
 
104 What is your current marital status?  
 Married...1 
 Living together...2 
 Single...3 
 Divorced...4 
 Widowed...5 
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For official 
use only 
  
 
 
 
 
 
 
 
 
105 
 
 
106 
Do you have children of your own?  
 
 
How many children do you have of your 
own? 
 No... 0-go to 107 
 Yes...1 
 
 
______    
 
 
 
107 
1) What is your highest educational 
qualification? 
 
 No schooling...1 
 Completed primary school (grade 7 or 
standard 5) ...2 
 Completed secondary school (grade 12 
or matric)...3 
 Diploma....4 
 University degree ...5 
 Other....9 
 
Specify:____________________ 
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For official 
use only 
  
 
 
 
 
108 
 
 
 
Are you currently employed?  
2) 
 No... 0 ---go to 201 
 Yes...1 
 
 
 
 
 
109 
3)  What kind of work do you do? Specify:____________________ 
 
 
SECTION 2: HIV DISCLOSURE AND TREATMENT  
For official 
use only 
   
 
 
 
201 When were you diagnosed as HIV positive?  O less than 6 months ago--1 
O 6-12 months ago--2 
O more than one year ago--3 
 
 
 
 
202 Have you told anyone else about your HIV status? O No   0---- go to 204 
O Yes --1 
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203 Who have you told about your HIV status O-no one--0 
 O Partner only--1 
O Own family member 
only(e.g. sister, brother, 
mother)--2 
O Friends only--3 
O Living openly with HIV--4 
O Other--9 
 specify ----------------- 
 
 
 
 
204 Are you currently on anti-retroviral treatment? 
O No-- 0---go to 206  
O Yes--1 
 
 
 
205 How long have you been on anti-retroviral therapy? 
 
 
………………….. months 
 
 
 
 
206    How would you rate your current health status 
O Poor—1 
O Satisfactory/Okay—2 
O Good—3 
O Excellent—4 
 
 
 
 
207 Have you experienced any form of discrimination as a 
result of your HIV status? 
O No--0  
O Yes--1 
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SECTION 3: REPRODUCTIVE CHOICES   
For official 
use only 
   
 
 
 
301 Which best describes your sexual relationship at this 
time 
O Not having sex--0 ---go to 
303 
O Having sex with one 
partner only--1 
O Having sex with more 
than one partner--2 
 
 
 
 
302 In the past 12 months, of all times you had sex with 
your partner (s), how often did you use a condom? 
O Never--0 
O Sometimes--1 
O Always--2 
O Did not have a main 
partner--9 
 
 
 
303 Do you wish to have a child/children in future O No--0  
O Yes—1- go to 306 
O Unsure/don’t know --3 
O Other--9 
Specify…………………… 
 
 
 
 
304 If you do not wish to have a child/ children, what form 
of contraception are you using? 
 
O Oral contraceptive--1 
O Injection--2 
O Other--9 
Specify………………………
……. 
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305 What are the reasons that you do not wish to have 
children? 
O I already have children of 
my own--1 
O My partner does not want a 
child--2 
O I am worried that the baby 
will be HIV positive--3 
O The doctor or sister advised 
me against it--4 
O I do not have  money to 
look after a baby--5 
O I am too sick to look after a 
baby--6 
O I am worried about stigma 
or discrimination--7 
O I do not have a stable 
partner at present--8 
O Other--9 
Specify…………………….. 
 
 
 
 
 
306 Could you tell us about the reasons that you want to 
have a child/ children? 
O I do not have a child/ 
children of my own--1 
O My partner wants a child--
2 
O My family or in-laws want 
a child--3 
O I am worried that people 
will gossip about me if I 
do not have a child--4 
O I feel healthy--5 
O I am now on ART--6 
O The sister or doctor spoke 
to me about having 
children--7 
O  Other--9 
Specify……………………… 
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307 How do you plan to have a child? O I will wait for the doctor to 
advise me/us--1 
O Natural methods --2 
O Artificial insemination--3 
O I don’t know--4 
O  Other--9 
Specify……………………… 
 
 
Section 4: Clinic services 
For official 
use only 
  
 
 
 
 
401 In the past 12 months, have you talked to a doctor or 
nurse about having a baby?  
O No--0 ---go to 404  
O Yes--1 
 
 
 
402 In the past 12 months, has any doctor talked to you 
about having a baby?  
O No--0  
O Yes--1 
 
 
 
403 In the past 12 months, has any nursing sister talked to 
you about having a baby?  
O No--0   
O Yes--1 
 
 
 
404 Have you attended any  information, session on any of 
the following:  
 
 
 
 
a Family planning or contraception for People Living 
with HIV 
O No--0 
O Yes--1 
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b Counselling on how to lower the risk of transmitting 
HIV to others 
O No--0 
O Yes--1 
 
 
 
c Prevention of mother-to-child transmission of HIV O No--0 
O Yes--1 
 
 
 
d Different ways of having a baby when one is HIV 
positive (e.g. artificial insemination or sperm washing) 
O No--0 
O Yes--1 
 
 
 
e ART and having a baby O No--0 
O Yes--1 
 
 
 
f Other, specify---------- O No--0 
O Yes   1 
 
 
 
405 Would you be interested in attending a session on 
sexual relationships for PLHIV? 
O No--0 
O Yes--1 
 
 
 
406 Would you be interested in attending a session on 
family planning or contraceptives for PLHIV? 
O No--0 
O Yes--1 
 
 
 
407 Would you be interested in attending a session on how 
PLHIV can have a child/ children? 
O No--0 
O Yes--1 
 
 
 
408 What type of setting would you prefer for this 
information (Choose only one answer?) 
O Individual one-on-one 
counselling--1 
O A women or men’s group--
2 
O A seminar or workshop--3 
O  Other--9 
Please specify……………… 
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SECTION 5. What additional information or support or services, if any, would you like 
to have available to you at the clinic? 
………………………………………………………………………………………………… 
THANK YOU VERY MUCH FOR YOUR PARTICIPATION 
 
 
